Status:
UNKNOWN
The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard Therapy
Lead Sponsor:
Fakultas Kedokteran Universitas Indonesia
Conditions:
Atopic Dermatitis
Immunoglobulin E Concentration, Serum
Eligibility:
All Genders
12-60 years
Phase:
PHASE3
Brief Summary
Extrinsic - atopic dermatitis is characterized by increased of IgE serum levels. Acute extrinsic - atopic dermatitis is a type 1 hypersensitivity that involve various inflammatory mediator including I...
Detailed Description
The aim of this study is to measure the efficacy of cimetidine for acute, extrinsic-atopic dermatitis treated with standard therapy using SCORAD as the clinical outcome. This study also measure Immuno...
Eligibility Criteria
Inclusion
- Atopic dermatitis patients diagnosed with Hanifin Rajka criteria
- Acute extrinsic atopic dermatitis
- IgE levels above 200 IU/mL
- Minimum weight 15kg
Exclusion
- Consumption of corticosteroid and systemic immunosuppressant within the last 2 weeks
- Chronic lesion
- Consumption of drugs that reacts with cimetidine
- Disturbance in lab results including complete blood count, liver function, and renal function.
- Other conditions that might increase IgE levels
Key Trial Info
Start Date :
March 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04018131
Start Date
March 26 2018
End Date
June 30 2020
Last Update
October 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Universitas Indonesia
Jakarta Pusat, Jakarta Special Capital Region, Indonesia, 10430